Deep phenotyping of miRNAs in exercise-induced cardiac hypertrophy and fibrosis

[1]  C. E. Condrat,et al.  miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis , 2020, Cells.

[2]  Xiaowei Wang,et al.  miRDB: an online database for prediction of functional microRNA targets , 2019, Nucleic Acids Res..

[3]  A. Doxakis,et al.  Targeting metalloproteinases in cardiac remodeling , 2019, Journal of Cardiovascular Medicine and Cardiology.

[4]  M. Care,et al.  Evaluation of cardiac hypertrophy in the setting of sudden cardiac death , 2019, Forensic sciences research.

[5]  C. Bouchard,et al.  The Effects of Regular Exercise on Circulating Cardiovascular-related MicroRNAs , 2019, Scientific Reports.

[6]  Xiaowei Wang,et al.  Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data , 2019, Genome Biology.

[7]  Junjie Xiao,et al.  MicroRNAs in heart and circulation during physical exercise , 2018, Journal of sport and health science.

[8]  J. Sadoshima,et al.  Mechanisms of physiological and pathological cardiac hypertrophy , 2018, Nature Reviews Cardiology.

[9]  S. Ellefsen,et al.  Adaptations to Endurance and Strength Training. , 2018, Cold Spring Harbor perspectives in medicine.

[10]  L. Burrell,et al.  Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy , 2018, International journal of molecular sciences.

[11]  P. Kohl,et al.  Cardiac fibroblasts , 2018, Herzschrittmachertherapie + Elektrophysiologie.

[12]  Peifeng Li,et al.  MicroRNA as a Therapeutic Target in Cardiac Remodeling , 2017, BioMed research international.

[13]  M. Masè,et al.  Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation , 2017, Scientific Reports.

[14]  Manuela Malatesta,et al.  Histological and Histochemical Methods - Theory and Practice , 2016, European journal of histochemistry : EJH.

[15]  M. Mohammadi,et al.  Phosphorylation of GSK-3β and reduction of apoptosis as targets of troxerutin effect on reperfusion injury of diabetic myocardium. , 2015, European journal of pharmacology.

[16]  A. Dávalos,et al.  Circulating inflammatory miRNA signature in response to different doses of aerobic exercise. , 2015, Journal of applied physiology.

[17]  B. Dieter,et al.  Evidence for distinct effects of exercise in different cardiac hypertrophic disorders. , 2015, Life sciences.

[18]  F. Reis,et al.  Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties , 2014, Diabetology & Metabolic Syndrome.

[19]  P. Thompson,et al.  Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise. , 2014, Journal of applied physiology.

[20]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[21]  Y. Pinto,et al.  The Therapeutic Potential of miRNAs in Cardiac Fibrosis: Where Do We Stand? , 2013, Journal of Cardiovascular Translational Research.

[22]  Yingtong Zeng,et al.  MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: A hypothesis , 2013, Medical science monitor : international medical journal of experimental and clinical research.

[23]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[24]  Z. Kassiri,et al.  Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease , 2012, Fibrogenesis & tissue repair.

[25]  J. Leenders,et al.  Repression of Cardiac Hypertrophy by KLF15: Underlying Mechanisms and Therapeutic Implications , 2012, PloS one.

[26]  K. Chowdhury,et al.  The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.

[27]  S. Gammeltoft,et al.  Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes , 2011, British journal of pharmacology.

[28]  J. Krieger,et al.  Aerobic Exercise Training–Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7) , 2011, Hypertension.

[29]  M. Irigoyen,et al.  MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. , 2011, Physiological genomics.

[30]  J. McMullen,et al.  Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. , 2010, Pharmacology & therapeutics.

[31]  V. Yang,et al.  Mammalian Krüppel-like factors in health and diseases. , 2010, Physiological reviews.

[32]  D. Mann,et al.  Clinical applications of miRNAs in cardiac remodeling and heart failure. , 2010, Personalized medicine.

[33]  E. Olson,et al.  Searching for miR-acles in cardiac fibrosis. , 2009, Circulation research.

[34]  W. Dillmann.  Cardiac hypertrophy and thyroid hormone signaling , 2009, Heart Failure Reviews.

[35]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[36]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[37]  Shay Artzi,et al.  miRNAminer: A tool for homologous microRNA gene search , 2008, BMC Bioinformatics.

[38]  Jamie K. Scott,et al.  Quantitation of DNA and RNA. , 2007, CSH protocols.

[39]  M. Lindsay,et al.  Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids , 2007, BMC Genomics.

[40]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[41]  Saptarsi M. Haldar,et al.  Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy , 2007, Proceedings of the National Academy of Sciences.

[42]  T. Karlsen,et al.  Aerobic high-intensity intervals improve VO2max more than moderate training. , 2007, Medicine and science in sports and exercise.

[43]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.

[44]  Saptarsi M. Haldar,et al.  The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. , 2006, Journal of molecular and cellular cardiology.

[45]  T. Murohara,et al.  Noninvasive Evaluation of the Time Course of Change in Cardiac Function in Spontaneously Hypertensive Rats by Echocardiography , 2005, Hypertension Research.

[46]  J. Krieger,et al.  Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[47]  C. Livi,et al.  HAND1 and HAND2 are expressed in the adult-rodent heart and are modulated during cardiac hypertrophy. , 2002, Biochemical and biophysical research communications.

[48]  C. Otto,et al.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49]  D. Srivastava,et al.  Human eHAND, but not dHAND, is down-regulated in cardiomyopathies. , 2001, Journal of molecular and cellular cardiology.

[50]  W. Roberts,et al.  Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[51]  G. de Simone,et al.  Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. , 1990, American journal of hypertension.

[52]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[53]  R. Stein,et al.  The cardiac response to exercise training: echocardiographic analysis at rest and during exercise. , 1980, The American journal of cardiology.

[54]  R. Jones,et al.  Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography. , 1980, The American journal of cardiology.

[55]  David R. Heise,et al.  Causal Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[56]  Avani A. Pendse,et al.  The Pathophysiology of Cardiac Hypertrophy and Heart Failure , 2014 .

[57]  N. Dhalla,et al.  Differences in Concentric Cardiac Hypertrophy and Eccentric Hypertrophy , 2013 .

[58]  U. Wisløff,et al.  Animal models in the study of exercise-induced cardiac hypertrophy. , 2010, Physiological research.

[59]  沈維道.  草蝦Kruppel-Like Factor蛋白質的功能性分析 , 2010 .

[60]  K. Tanonaka,et al.  Preferable anesthetic conditions for echocardiographic determination of murine cardiac function. , 2005, Journal of pharmacological sciences.

[61]  B. Maron.  Structural features of the athlete heart as defined by echocardiography. , 1986, Journal of the American College of Cardiology.

[62]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .